【4503】アステラス薬

Astellas to Acquire Ocata Therapeutics
2015-11-10(12:00)

関連タグ:








Astellas to Acquire Ocata Therapeutics
- New Step Forward in Ophthalmology with Cell Therapy Approach Tokyo and Massachusetts, November 10, 2015 - Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, “Astellas”) and Ocata Therapeutics, Inc. (NASDAQ: OCAT, President and CEO: Paul Wotton, “Ocata”), a biotechnology company focused on the research and development of new therapies in the field of regenerative medicine, primarily cell therapy addressing unmet medical needs in ophthalmology patients, announced today that they have entered into a definitive agreement. Under the agre
				

関連タグ:



  Astellas to Acquire Ocata Therapeutics






日付 始値 高値 安値 終値 出来高
2015-11-20 1720 1744 1718 1740 7192400
2015-11-19 1760 1765 1730 1734 9589300
2015-11-18 1730 1753 1725 1732 8682800
2015-11-17 1752 1754 1721 1726 10090900
2015-11-16 1730 1748 1708 1737 6267900
2015-11-13 1762 1762 1735 1753 7800800
2015-11-12 1764 1793 1745 1770 7977700
2015-11-11 1784 1784 1731 1764 9881100
2015-11-10 1773 1801 1770 1801 8662200
2015-11-09 1776 1804 1772 1802 8390200
2015-11-06 1768 1789 1762 1786 4487800
2015-11-05 1765 1784 1761 1768 7400400
2015-11-04 1740 1782 1740 1751 9608200
2015-11-02 1748 1759 1708 1718 7785500

関連情報
曜日別開示状況
年月